Discover the REMODEL-1 Study and Help Fight Multiple Sclerosis

We’re excited to introduce you to the REMODEL-1 Study, a clinical trial that offers hope and a new potential treatment option for those living with relapsing multiple sclerosis (RMS).
Learn how you can get involved.
SC3 logo-1

Learn about this active study and what's in it for you .

Cream Black Illustrated Guidebook For UGC Content Creators Wattpad Book Cover (2)-1
Download Study Brochure

Get a comprehensive understanding of this active clinical trial, how you can contribute to the advancement of MS treatments, and the potential benefits of participating.

Fill out the form below to receive your downloadable brochure via email.

Contact the local study team for personalized and specific help regarding this MS trial. 

The Need for New MS Treatments

While there are therapies available for relapsing MS, there's still a critical need for more effective and accessible therapies. Treatment options may have limitations such as:

Side effects: Some MS medications can have significant side effects that affect daily life.
Effectiveness: Not all treatments work for everyone, and effectiveness can sometimes decrease over time.
Accessibility: Certain treatments require frequent infusions or injections, which can be inconvenient and time consuming.

oral-acne-medication-guide
cr=w_600,h_300

Why this MS Study Matters

This clinical trial is essential because it's investigating a potential new treatment option for people with relapsing MS. It aims to address the limitations of existing therapies and pave the way towards better outcomes for those living with MS.

 

Eligibility Criteria

  • 18 to 55 years of age
  • Diagnosis of RMS according to the 2017 McDonald diagnostic criteria
  • At least: 1 documented relapse within the previous year. OR 2 documented relapses within the previous 2 years, OR 1 active Gadolinium (Gd)-enhancing lesion in the 12 months.
  • EDSS score of 0 to 5.5 (inclusive)
  • Neurologically stable within 1 month
Featured -1

Why you should participate

Gain access to the latest, cutting-edge treatments for MS
Close care and monitoring from Multiple Sclerosis specialists.
Play a key role in advancing MS research and improving the lives of others
Reimbursement for study-related time and travel expenses.

If you decide to join this study, your health and safety will carefully be monitored by specialists, and your participation will help doctors evaluate the study drugs to measure their effectiveness. 

Our research needs you

Our goal at SC3 Research is to advance the discovery of treatments for neurodegenerative disorders like Multiple Sclerosis. We are researching MS therapies where it matters the most. 

Symptom Management and Quality of Life Improvement
We understand that MS can have a significant impact on daily living, and our research aims to develop novel therapies to manage and alleviate MS symptoms. By addressing common symptoms such as fatigue, spasticity, and pain, we seek to improve the overall quality of life for people affected by MS.
Personalized Medicine
Our team is actively exploring the potential of personalized medicine in the treatment of MS. By identifying genetic, molecular, and environmental factors that may contribute to the development and progression of MS, we aim to develop tailored therapies that can be more effective for individual patients.
Innovative Clinical Trial Design
At SC3 Research Group, we embrace innovation in clinical trial design to enhance the efficiency and effectiveness of our studies. By incorporating adaptive trial designs, real-world evidence, and digital technologies, we strive to accelerate the development and approval of new therapies for MS.

Together, we can create a world free of Multiple Sclerosis. Join us in this study and make a lasting impact. Sign up now!

How to Get Involved

  • Attractive young woman working on a desktop computer smiling as she leans forwards reading text on the screen, view over the monitor
    Step 1: Connect with us
    Fill out the form below, providing your name, email, and phone number. One of our study members will reach out to you at your preferred time to personally assist you during the pre-screening process.
  • Picture of smiling nurse assisting senior man
    Step 2: Get screened
    Our study team will conduct additional screening procedures to determine your eligibility for participation
  • Portrait of happy female patient showing thumbs up sign while standing with doctor in clinic-1
    Step 3: Enroll in a clinical study
    If you're confirmed eligible after screening, you'll be required to understand and sign an informed consent form. Once enrolled, you may be asked to make scheduled visits over a period of time.

Participate in REMODEL-1 Multiple Sclerosis Study

Help shape the future of MS treatment. We invite you to learn more about this study. To learn if you qualify for participation, please fill out this contact form. Better yet, call us or see us in person. 

Point Of Contact

Roxanne Cabading - Study Staff

Phone

626-250-2070

Email

roxanne.cabading@neuro-search-usa.com
Cream Black Illustrated Guidebook For UGC Content Creators Wattpad Book Cover (3)-1-1

Our MS Community Gallery

 Discover a vibrant space where MS patients, their loved ones, and passionate advocates connect, share their experiences, and inspire hope.

Check out some snaps from the MS Community 

Join the Conversation!

About SC3 Research Group

SC3 Research Group is a leading clinical research organization dedicated to advancing the understanding and treatment of Multiple Sclerosis. Our team of expert researchers, clinicians, and support staff work tirelessly to bring innovative therapies and solutions to those living with this challenging condition. By partnering with healthcare providers, biopharmaceutical companies, and other stakeholders, we strive to improve the lives of individuals affected by MS through the power of clinical research.
Check Enrolling Clinical Trials

Clinical research site locations near you

SC3 Research Group, Inc. has clinical research site locations at Pasadena, Reseda, and Beverly Grove.

SC3 Research Group, Inc - Pasadena

Phone: (626) 250-2070

Address: 5960 E. Green St., Suite 310, Pasadena, CA 91106